Suchergebnisse - "Ashraf, Sajda"

PubPharm (48)

1

Indenoquinoxaline-phenylacrylohydrazide hybrids as promising drug candidates for the treatment of type 2 diabetes : In vitro and in silico evaluation of enzyme inhibition and antioxidant activity

enthalten in: International journal of biological macromolecules | 2024

von Hameed, S. | Saleem, F. | Özil, M. | +6

2

Oxadiazole Derivatives of Diclofenac as an Anti-proliferative Agent for B-cell Non-Hodgkin Lymphoma : An In vitro and In Silico Studies

enthalten in: Medicinal chemistry (Shariqah (United Arab Emirates)) | 2024

von Qayyum, S. | Jabeen, A. | Ashraf, S. | +4

3

Exploring pyrrolidinyl-spirooxindole natural products as promising platforms for the synthesis of novel spirooxindoles as EGFR/CDK2 inhibitors for halting breast cancer cells

enthalten in: Frontiers in chemistry | 2024

von Nafie, M. | Al-Majid, A. | Ali, M. | +6

4

Exploring the viral protease inhibitor space driven by consensus scoring-based virtual screening

enthalten in: In silico pharmacology | 2024

von Mushtaq, M. | Naz, S. | Ashraf, S. | +3

5

New spiro-indeno[1,2-b]quinoxalines clubbed with benzimidazole scaffold as CDK2 inhibitors for halting non-small cell lung cancer; stereoselective synthesis, molecular dynamics and structural insights

enthalten in: Journal of enzyme inhibition and medicinal chemistry | 2023

von Barakat, A. | Alshahrani, S. | Al-Majid, A. | +8

6

Exploring the viral protease inhibitor space driven by consensus scoring-based virtual screening

enthalten in: In Silico Pharmacology | 2023

von Mushtaq, M. | Naz, S. | Ashraf, S. | +3

7

Synthesis, crystal structure, DFT, Hirshfeld surface analysis, energy frameworks and in-Silico drug-targeting PFKFB3 kinase of novel triazolequinoxalin derivative (TZQ) as a therapeutic Strategy against cancer

enthalten in: Heliyon | 2023

von Abad, N. | Al-Ostoot, F. | Ashraf, S. | +9

8

Multicomponent diastereoselective synthesis of tetrahydropyridines as α-amylase and α-glucosidase enzymes inhibitors

enthalten in: Future medicinal chemistry | 2023

von Saleem, F. | Shamim, F. | Özil, M. | +7

9

Discovery of drug targets and therapeutic agents based on drug repositioning to treat lung adenocarcinoma

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Graves, O. | Kim, W. | Özcan, M. | +6

10

Epigenetic modulation by targeting bromodomain containing protein 9 (BRD9) : Its therapeutic potential and selective inhibition

enthalten in: International journal of biological macromolecules | 2023

von Ali, M. | Naz, S. | Ashraf, S. | +2

1
2
3
4
5
Nächster »
[5]